Poorly controlled type II diabetes mellitus significantly enhances postoperative chemoresistance in patients with stage III colon cancer

doi:10.3748/wjg.v31.i3.98688

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2040)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

HTML

858

Figures (1-2)

247

Tables (1-5)

206

Sum=1347

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

111

Download

306

Sum=417

Publishing Process of This Article

Item

Count

Browse

Download

168

Sum=215

Jan 21, 2025 (publication date) through Apr 24, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Jan 21, 2025; 31(3): 98688
Published online Jan 21, 2025. doi: 10.3748/wjg.v31.i3.98688

Full Size Figure Download Figure

Figure 1 Study flow chart. ¹Defined as the American Society of Anesthesiologists classification > III or New York Heart Association classification> II. ²Defined as Clavien-Dindo classification > II. DM: Diabetes mellitus; TNM: Tumor-node-metastasis.

Citation: Guan RY, Wu JW, Yuan ZY, Liu ZY, Liu ZZ, Xiao ZC, Li JH, Huang CZ, Wang JJ, Yao XQ. Poorly controlled type II diabetes mellitus significantly enhances postoperative chemoresistance in patients with stage III colon cancer. World J Gastroenterol 2025; 31(3): 98688
URL: https://www.wjgnet.com/1007-9327/full/v31/i3/98688.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i3.98688